Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 9537901, 12 pages
http://dx.doi.org/10.1155/2016/9537901
Review Article

Anti-Inflammation of Natural Components from Medicinal Plants at Low Concentrations in Brain via Inhibiting Neutrophil Infiltration after Stroke

1Department of Neurology, Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China
2Hebei Collaborative Innovation Center for Cardiocerebrovascular Disease, Shijiazhuang, Hebei 050000, China
3Hebei Vascular Homeostasis Key Laboratory for Neurology, Shijiazhuang, Hebei 050000, China

Received 4 February 2016; Revised 27 May 2016; Accepted 14 June 2016

Academic Editor: Chang-Shik Yin

Copyright © 2016 Jiannan Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Go, D. Mozaffarian, V. L. Roger et al., “Heart disease and stroke statistics—2014 update: a report from the American Heart Association,” Circulation, vol. 129, no. 3, pp. e28–e292, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. A. S. Go, D. Mozaffarian, V. L. Roger et al., “Heart disease and stroke statistics-2013 update: a report from the American Heart Association,” Circulation, vol. 127, no. 1, pp. e6–e245, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Xing, K. Arai, E. H. Lo, and M. Hommel, “Pathophysiologic cascades in ischemic stroke,” International Journal of Stroke, vol. 7, no. 5, pp. 378–385, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Gu, J. Chen, and J. Shen, “Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets,” Journal of Neuroimmune Pharmacology, vol. 9, no. 3, pp. 313–339, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Campanella, C. Sciorati, G. Tarozzo, and M. Beltramo, “Flow cytometric analysis of inflammatory cells in ischemic rat brain,” Stroke, vol. 33, no. 2, pp. 586–592, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. R. K. Clark, E. V. Lee, C. J. Fish et al., “Development of tissue damage, inflammation and resolution following stroke: an immunohistochemical and quantitative planimetric study,” Brain Research Bulletin, vol. 31, no. 5, pp. 565–572, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Beck and K. H. Plate, “Angiogenesis after cerebral ischemia,” Acta Neuropathologica, vol. 117, no. 5, pp. 481–496, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Fan and G.-Y. Yang, “Therapeutic angiogenesis for brain ischemia: a brief review,” Journal of Neuroimmune Pharmacology, vol. 2, no. 3, pp. 284–289, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. M. I. Weintraub, “Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire,” Stroke, vol. 37, no. 7, pp. 1917–1922, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. N. V. Grønberg, F. F. Johansen, U. Kristiansen, and H. Hasseldam, “Leukocyte infiltration in experimental stroke,” Journal of Neuroinflammation, vol. 10, article 115, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Tzounis, J. Vulevic, G. G. C. Kuhnle et al., “Flavanol monomer-induced changes to the human faecal microflora,” British Journal of Nutrition, vol. 99, no. 4, pp. 782–792, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. J. P. E. Spencer, “The impact of flavonoids on memory: physiological and molecular considerations,” Chemical Society Reviews, vol. 38, no. 4, pp. 1152–1161, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Zhang, F. Xia, Y. Zhang et al., “Ginsenoside Rd is efficacious against acute ischemic stroke by suppressing microglial proteasome-mediated inflammation,” Molecular Neurobiology, vol. 53, no. 4, pp. 2529–2540, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Ruan, H. M. Wang, X. T. Huang et al., “A novel caffeoyl triterpene attenuates cerebral ischemic injury with potent anti-inflammatory and hypothermic effects,” Journal of Neurochemistry, vol. 133, no. 1, pp. 93–103, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Zhu, Y. Jiang, L. Wu, T. Lu, G. Xu, and X. Liu, “Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia,” Neuroscience, vol. 202, pp. 342–351, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Girbovan and H. Plamondon, “Resveratrol downregulates type-1 glutamate transporter expression and microglia activation in the hippocampus following cerebral ischemia reperfusion in rats,” Brain Research, vol. 1608, pp. 203–214, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Yu, F. Chen, and C. Li, “Absorption, disposition, and pharmacokinetics of saponins from Chinese medicinal herbs: what do we know and what do we need to know more?” Current Drug Metabolism, vol. 13, no. 5, pp. 577–598, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. W.-J. Zhang, P. Hufnagl, B. R. Binder, and J. Wojta, “Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-κB activation and adhesion molecule expression,” Thrombosis and Haemostasis, vol. 90, no. 5, pp. 904–914, 2003. View at Google Scholar · View at Scopus
  19. B. Ni, Z. Cao, and Y. Liu, “Glycyrrhizin protects spinal cord and reduces inflammation in spinal cord ischemia-reperfusion injury,” International Journal of Neuroscience, vol. 123, no. 11, pp. 745–751, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. X.-M. Hu, Y. Zhang, and F.-D. Zeng, “Effects of sodium β-aescin on expression of adhesion molecules and migration of neutrophils after middle cerebral artery occlusion in rats,” Acta Pharmacologica Sinica, vol. 25, no. 7, pp. 869–875, 2004. View at Google Scholar · View at Scopus
  21. J. Huang, U. M. Upadhyay, and R. J. Tamargo, “Inflammation in stroke and focal cerebral ischemia,” Surgical Neurology, vol. 66, no. 3, pp. 232–245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Krupinski, J. Kaluza, P. Kumar, S. Kumar, and J. M. Wang, “Role of angiogenesis in patients with cerebral ischemic stroke,” Stroke, vol. 25, no. 9, pp. 1794–1798, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Kolaczkowska and P. Kubes, “Neutrophil recruitment and function in health and inflammation,” Nature Reviews Immunology, vol. 13, no. 3, pp. 159–175, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Mo, T. Li, G. Ji, W. Lu, and Z. Hu, “Peripheral polymorphonuclear leukocyte activation as a systemic inflammatory response in ischemic stroke,” Neurological Sciences, vol. 34, no. 9, pp. 1509–1516, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. G. C. Jickling, D. Liu, B. P. Ander, B. Stamova, X. Zhan, and F. R. Sharp, “Targeting neutrophils in ischemic stroke: translational insights from experimental studies,” Journal of Cerebral Blood Flow and Metabolism, vol. 35, no. 6, pp. 888–901, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. D. W. Howells, M. J. Porritt, S. S. J. Rewell et al., “Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia,” Journal of Cerebral Blood Flow & Metabolism, vol. 30, no. 8, pp. 1412–1431, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Morancho, L. García-Bonilla, V. Barceló et al., “A new method for focal transient cerebral ischaemia by distal compression of the middle cerebral artery,” Neuropathology and Applied Neurobiology, vol. 38, no. 6, pp. 617–627, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. S. T. Carmichael, “Rodent models of focal stroke: size, mechanism, and purpose,” NeuroRx, vol. 2, no. 3, pp. 396–409, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Llovera, S. Roth, N. Plesnila, R. Veltkamp, and A. Liesz, “Modeling stroke in mice: permanent coagulation of the distal middle cerebral artery,” Journal of Visualized Experiments, vol. 4, no. 89, Article ID e51729, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Zhang, X. Zhang, X. Liu et al., “Chrysophanol inhibits nalp3 inflammasome activation and ameliorates cerebral ischemia/reperfusion in mice,” Mediators of Inflammation, vol. 2014, Article ID 370530, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. K. E. Sandoval and K. A. Witt, “Blood-brain barrier tight junction permeability and ischemic stroke,” Neurobiology of Disease, vol. 32, no. 2, pp. 200–219, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. S. M. Gloor, M. Wachtel, M. F. Bolliger, H. Ishihara, R. Landmann, and K. Frei, “Molecular and cellular permeability control at the blood-brain barrier,” Brain Research Reviews, vol. 36, no. 2-3, pp. 258–264, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Daneman, “The blood-brain barrier in health and disease,” Annals of Neurology, vol. 72, no. 5, pp. 648–672, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. W. M. Pardridge, “Drug transport across the blood-brain barrier,” Journal of Cerebral Blood Flow and Metabolism, vol. 32, no. 11, pp. 1959–1972, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Knowland, A. Arac, K. J. Sekiguchi et al., “Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke,” Neuron, vol. 82, no. 3, pp. 603–617, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Kuroiwa, P. Ting, H. Martinez, and I. Klatzo, “The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion,” Acta Neuropathologica, vol. 68, no. 2, pp. 122–129, 1985. View at Publisher · View at Google Scholar · View at Scopus
  37. X.-D. Wu, L.-N. Du, G.-C. Wu, and X.-D. Cao, “Effects of electroacupuncture on blood-brain barrier after cerebral ischemia-reperfusion in rat,” Acupuncture and Electro-Therapeutics Research, vol. 26, no. 1-2, pp. 1–9, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. O. B. Dimitrijevic, S. M. Stamatovic, R. F. Keep, and A. V. Andjelkovic, “Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury,” Journal of Cerebral Blood Flow and Metabolism, vol. 26, no. 6, pp. 797–810, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Jiao, Z. Wang, Y. Liu, P. Wang, and Y. Xue, “Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult,” Journal of Molecular Neuroscience, vol. 44, no. 2, pp. 130–139, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. G. A. Rosenberg, E. Y. Estrada, and J. E. Dencoff, “Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain,” Stroke, vol. 29, no. 10, pp. 2189–2195, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. M. K. Başkaya, A. M. Rao, A. Doǧan, D. Donaldson, and R. J. Dempsey, “The biphasic opening of the blood-brain barrier in the cortex and hippocampus after traumatic brain injury in rats,” Neuroscience Letters, vol. 226, no. 1, pp. 33–36, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. A. L. Betz, “Alterations in cerebral endothelial cell function in ischemia,” Advances in Neurology, vol. 71, pp. 311–313, 1996. View at Google Scholar · View at Scopus
  43. R. Brambilla, Y. Couch, and K. L. Lambertsen, “The effect of stroke on immune function,” Molecular and Cellular Neuroscience, vol. 53, pp. 26–33, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. G. J. del Zoppo, G. W. Schmid-Schönbein, E. Mori, B. R. Copeland, and C.-M. Chang, “Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons,” Stroke, vol. 22, no. 10, pp. 1276–1283, 1991. View at Publisher · View at Google Scholar · View at Scopus
  45. Z. G. Del, “Microvascular changes during cerebral ischemia and reperfusion,” Cerebrovascular and Brain Metabolism Reviews Journal, vol. 6, no. 1, pp. 47–96, 1994. View at Google Scholar
  46. G. B. Segel, M. W. Halterman, and M. A. Lichtman, “The paradox of the neutrophil's role in tissue injury,” Journal of Leukocyte Biology, vol. 89, no. 3, pp. 359–372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Iadecola and J. Anrather, “The immunology of stroke: from mechanisms to translation,” Nature Medicine, vol. 17, no. 7, pp. 796–808, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Maeda and B. Fadeel, “Mitochondria released by cells undergoing TNF-α-induced necroptosis act as danger signals,” Cell Death and Disease, vol. 5, no. 7, article e1312, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. F. Yang, Z. Wang, X. Wei et al., “NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke,” Journal of Cerebral Blood Flow & Metabolism, vol. 34, no. 4, pp. 660–667, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. X. Z. West, N. L. Malinin, A. A. Merkulova et al., “Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands,” Nature, vol. 467, no. 7318, pp. 972–976, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. B. McDonald, K. Pittman, G. B. Menezes et al., “Intravascular danger signals guide neutrophils to sites of sterile inflammation,” Science, vol. 330, no. 6002, pp. 362–366, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. D. Dimasi, W. Y. Sun, and C. S. Bonder, “Neutrophil interactions with the vascular endothelium,” International Immunopharmacology, vol. 17, no. 4, pp. 1167–1175, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. U. Dirnagl, C. Iadecola, and M. A. Moskowitz, “Pathobiology of ischaemic stroke: an integrated view,” Trends in Neurosciences, vol. 22, no. 9, pp. 391–397, 1999. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Ley, C. Laudanna, M. I. Cybulsky, and S. Nourshargh, “Getting to the site of inflammation: the leukocyte adhesion cascade updated,” Nature Reviews Immunology, vol. 7, no. 9, pp. 678–689, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Zarbock, K. Ley, R. P. McEver, and A. Hidalgo, “Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow,” Blood, vol. 118, no. 26, pp. 6743–6751, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. H. Morrison, D. McKee, and L. Ritter, “Systemic neutrophil activation in a mouse model of ischemic stroke and reperfusion,” Biological Research for Nursing, vol. 13, no. 2, pp. 154–163, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Darbousset, G. M. Thomas, S. Mezouar et al., “Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation,” Blood, vol. 120, no. 10, pp. 2133–2143, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. M.-L. von Brühl, K. Stark, A. Steinhart et al., “Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo,” Journal of Experimental Medicine, vol. 209, no. 4, pp. 819–835, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Jin, S. Yu, Z. Song et al., “Soluble CD40 ligand stimulates CD40-dependent activation of the β2 integrin Mac-1 and protein kinase C Zeda (PKCζ) in neutrophils: implications for neutrophil-platelet interactions and neutrophil oxidative burst,” PLoS ONE, vol. 8, no. 6, article e64631, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. C. Allen, P. Thornton, A. Denes et al., “Neutrophil cerebrovascular transmigration triggers rapid neurotoxicity through release of proteases associated with decondensed DNA,” The Journal of Immunology, vol. 189, no. 1, pp. 381–392, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. S. E. Lakhan, A. Kirchgessner, and M. Hofer, “Inflammatory mechanisms in ischemic stroke: therapeutic approaches,” Journal of Translational Medicine, vol. 7, article 97, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. K. L. Lambertsen, K. Biber, and B. Finsen, “Inflammatory cytokines in experimental and human stroke,” Journal of Cerebral Blood Flow and Metabolism, vol. 32, no. 9, pp. 1677–1698, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. K. L. Lambertsen, R. Gregersen, and B. Finsen, “Microglial-macrophage synthesis of tumor necrosis factor after focal cerebral ischemia in mice is strain dependent,” Journal of Cerebral Blood Flow and Metabolism, vol. 22, no. 7, pp. 785–797, 2002. View at Google Scholar · View at Scopus
  64. J. Zaremba and J. Losy, “Cytokines in clinical and experimental ischemic stroke,” Neurologia I Neurochirurgia Polska, vol. 38, no. 1, supplement 1, pp. S57–S62, 2004. View at Google Scholar · View at Scopus
  65. L. Chang, Y. Chen, J. Li et al., “Cocaine-and amphetamine-regulated transcript modulates peripheral immunity and protects against brain injury in experimental stroke,” Brain, Behavior, and Immunity, vol. 25, no. 2, pp. 260–269, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. Yamasaki, N. Matsuura, H. Shozuhara et al., “Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats,” Stroke, vol. 26, no. 4, pp. 676–681, 1995. View at Publisher · View at Google Scholar · View at Scopus
  67. H. Boutin, R. A. LeFeuvre, R. Horai, M. Asano, Y. Iwakura, and N. J. Rothwell, “Role of IL-1alpha and IL-1beta in ischemic brain damage,” The Journal of Neuroscience, vol. 21, no. 15, pp. 5528–5534, 2001. View at Google Scholar · View at Scopus
  68. F. C. Barone and G. Z. Feuerstein, “Inflammatory mediators and stroke: new opportunities for novel therapeutics,” Journal of Cerebral Blood Flow and Metabolism, vol. 19, no. 8, pp. 819–834, 1999. View at Google Scholar · View at Scopus
  69. K. Kozuka, T. Kohriyama, E. Nomura, J. Ikeda, H. Kajikawa, and S. Nakamura, “Endothelial markers and adhesion molecules in acute ischemic stroke—sequential change and differences in stroke subtype,” Atherosclerosis, vol. 161, no. 1, pp. 161–168, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. X. Wang, A.-L. Siren, Y. Liu, T.-L. Yue, F. C. Barone, and G. Z. Feuerstein, “Upregulation of intercellular adhesion molecule 1 (ICAM-1) on brain microvascular endothelial cells in rat ischemic cortex,” Molecular Brain Research, vol. 26, no. 1-2, pp. 61–68, 1994. View at Publisher · View at Google Scholar · View at Scopus
  71. R. L. Zhang, M. Chopp, N. Jiang et al., “Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat,” Stroke, vol. 26, no. 8, pp. 1438–1443, 1995. View at Publisher · View at Google Scholar · View at Scopus
  72. K. Kitagawa, M. Matsumoto, T. Mabuchi et al., “Deficiency of intercellular adhesion molecule 1 attenuates microcirculatory disturbance and infarction size in focal cerebral ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 18, no. 12, pp. 1336–1345, 1998. View at Google Scholar · View at Scopus
  73. J. Huang, T. F. Choudhri, C. J. Winfree et al., “Postischemic cerebrovascular E-selectin expression mediates tissue injury in murine stroke,” Stroke, vol. 31, no. 12, pp. 3047–3053, 2000. View at Publisher · View at Google Scholar · View at Scopus
  74. J. Mocco, T. Choudhri, J. Huang et al., “HuEP5C7 as a humanized monoclonal anti-E/P-selectin neurovascular protective strategy in a blinded placebo-controlled trial of nonhuman primate stroke,” Circulation Research, vol. 91, no. 10, pp. 907–914, 2002. View at Publisher · View at Google Scholar · View at Scopus
  75. A. Y. Jin, U. I. Tuor, D. Rushforth et al., “Reduced blood brain barrier breakdown in P-selectin deficient mice following transient ischemic stroke: a future therapeutic target for treatment of stroke,” BMC Neuroscience, vol. 11, article 12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. S. G. Soriano, A. Coxon, Y. F. Wang et al., “Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury,” Stroke, vol. 30, no. 1, pp. 134–139, 1999. View at Publisher · View at Google Scholar · View at Scopus
  77. M. A. Yenari, D. Kunis, G. H. Sun et al., “Hu23F2G, an antibody recognizing the leukocyte CD11/CD18 integrin, reduces injury in a rabbit model of transient focal cerebral ischemia,” Experimental Neurology, vol. 153, no. 2, pp. 223–233, 1998. View at Publisher · View at Google Scholar · View at Scopus
  78. P. M. Hughes, P. R. Allegrini, M. Rudin, V. H. Perry, A. K. Mir, and C. Wiessner, “Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model,” Journal of Cerebral Blood Flow and Metabolism, vol. 22, no. 3, pp. 308–317, 2002. View at Google Scholar · View at Scopus
  79. Y. Kumai, H. Ooboshi, J. Takada et al., “Anti-monocyte chemoattractant protein-1 gene therapy protects against focal brain ischemia in hypertensive rats,” Journal of Cerebral Blood Flow and Metabolism, vol. 24, no. 12, pp. 1359–1368, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. J. S. Kim, S. C. Gautam, M. Chopp et al., “Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat,” Journal of Neuroimmunology, vol. 56, no. 2, pp. 127–134, 1995. View at Publisher · View at Google Scholar · View at Scopus
  81. X. Wang, T.-L. Yue, F. C. Barone, and G. Z. Feuerstein, “Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex,” Stroke, vol. 26, no. 4, pp. 661–666, 1995. View at Publisher · View at Google Scholar · View at Scopus
  82. N. G. Gourmala, M. Buttini, S. Limonta, A. Sauter, and H. W. G. M. Boddeke, “Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration,” Journal of Neuroimmunology, vol. 74, no. 1-2, pp. 35–44, 1997. View at Publisher · View at Google Scholar · View at Scopus
  83. H. Qin, P. Liu, and S. Lin, “Effects of astragaloside IV on the SDF-1/CXCR4 expression in atherosclerosis of apoE-/- mice induced by hyperlipaemia,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 385154, 8 pages, 2015. View at Publisher · View at Google Scholar
  84. Y. Luo, Z. Qin, Z. Hong et al., “Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia,” Neuroscience Letters, vol. 363, no. 3, pp. 218–223, 2004. View at Publisher · View at Google Scholar · View at Scopus
  85. Y.-Y. Yin, W.-P. Li, H.-L. Gong, F.-F. Zhu, W.-Z. Li, and G.-C. Wu, “Protective effect of astragaloside on focal cerebral ischemia/reperfusion injury in rats,” American Journal of Chinese Medicine, vol. 38, no. 3, pp. 517–527, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Li, Y. Z. Qu, Z. W. Zhao et al., “Astragaloside IV protects against focal cerebral ischemia/reperfusion injury correlating to suppression of neutrophils adhesion-related molecules,” Neurochemistry International, vol. 60, no. 5, pp. 458–465, 2012. View at Publisher · View at Google Scholar · View at Scopus
  87. Q.-S. Liu, H.-F. Wang, A.-K. Sun et al., “A comparative study on inhibition of total astragalus saponins and astragaloside IV on TNFR1-mediated signaling pathways in arterial endothelial cells,” PLoS ONE, vol. 9, no. 7, Article ID e101504, 2014. View at Publisher · View at Google Scholar · View at Scopus
  88. W.-J. Zhang and B. Frei, “Astragaloside IV inhibits NF-κB activation and inflammatory gene expression in LPS-treated mice,” Mediators of Inflammation, vol. 2015, Article ID 274314, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  89. X.-P. Huang, H. Ding, J.-D. Lu, Y.-H. Tang, B.-X. Deng, and C.-Q. Deng, “Effects of the combination of the main active components of Astragalus and Panax notoginseng on inflammation and apoptosis of nerve cell after cerebral ischemia-reperfusion,” American Journal of Chinese Medicine, vol. 43, no. 7, pp. 1419–1438, 2015. View at Publisher · View at Google Scholar · View at Scopus
  90. D. Gui, J. Huang, Y. Guo et al., “Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression,” Cytokine, vol. 61, no. 3, pp. 970–977, 2013. View at Publisher · View at Google Scholar · View at Scopus
  91. S. Kim, C. Lim, H. Lee, and J. Lee, “The use of Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, in robust neuroprotection in the postischemic brain,” Anatomy & Cell Biology, vol. 44, no. 4, pp. 304–313, 2011. View at Publisher · View at Google Scholar
  92. S. Ishida, Y. Sakiya, T. Ichikawa, Z. Taira, and S. Awazu, “Prediction of glycyrrhizin disposition in rat and man with liver failure by a physiologically based pharmacokinetic model,” Journal of Pharmacobio-Dynamics, vol. 13, no. 2, pp. 142–157, 1990. View at Publisher · View at Google Scholar · View at Scopus
  93. T.-H. Tsai, J.-F. Liao, A. Y.-C. Shum, and C.-F. Chen, “Pharmacokinetics of glycyrrhizin after intravenous administration to rats,” Journal of Pharmaceutical Sciences, vol. 81, no. 9, pp. 961–963, 1992. View at Publisher · View at Google Scholar · View at Scopus
  94. S. Ishida, T. Ichikawa, and Y. Sakiya, “Binding of glycyrrhetinic acid to rat plasma, rat serum albumin, human serum, and human serum albumin,” Chemical and Pharmaceutical Bulletin, vol. 36, no. 1, pp. 440–443, 1988. View at Publisher · View at Google Scholar · View at Scopus
  95. S. Ishida, Y. Sakiya, T. Ichikawa, M. Kinoshita, and S. Awazu, “Binding of glycyrrhizin to human serum and human serum albumin,” Chemical and Pharmaceutical Bulletin, vol. 37, no. 1, pp. 226–228, 1989. View at Publisher · View at Google Scholar · View at Scopus
  96. H. Xiong, Y. Xu, G. Tan et al., “Glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c Mice and inhibits TNF-α-induced ICAM-1 expression via NF-κB/MAPK in HaCaT Cells,” Cellular Physiology and Biochemistry, vol. 35, no. 4, pp. 1335–1346, 2015. View at Publisher · View at Google Scholar · View at Scopus
  97. W. Huang, X. Chen, Q. Li et al., “Inhibition of intercellular adhesion in herpex simplex virus infection by glycyrrhizin,” Cell Biochemistry and Biophysics, vol. 62, no. 1, pp. 137–140, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. N. Nakata, Y. Kira, Y. Yabunaka, and K. Takaoka, “Prevention of venous thrombosis by preoperative glycyrrhizin infusion in a rat model,” Journal of Orthopaedic Science, vol. 13, no. 5, pp. 456–462, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. A. Mabuchi, K. Wake, M. Marlini, H. Watanabe, and A. M. Wheatley, “Protection by glycyrrhizin against warm ischemia-reperfusioninduced cellular injury and derangement of the microcirculatory blood flow in the rat liver,” Microcirculation, vol. 16, no. 4, pp. 364–376, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. Y.-F. Ni, J.-K. Kuai, Z.-F. Lu et al., “Glycyrrhizin treatment is associated with attenuation of lipopolysaccharide-induced acute lung injury by inhibiting cyclooxygenase-2 and inducible nitric oxide synthase expression,” Journal of Surgical Research, vol. 165, no. 1, pp. e29–e35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. N. Nakata and K. Takaoka, “Use of glycyrrhizin in prevention of tissue damage caused by ischemia-reperfusion in rabbit hind limbs,” Journal of Orthopaedic Science, vol. 11, no. 4, pp. 375–379, 2006. View at Publisher · View at Google Scholar · View at Scopus
  102. X.-M. Hu and F.-D. Zeng, “Protective effects of sodium beta-aescin on ischemia-reperfusion injury in rat brain,” Yao Xue Xue Bao, vol. 39, no. 6, pp. 419–423, 2004. View at Google Scholar · View at Scopus
  103. J. Liu, Y. Li, X. Yuan, Z. Yang, and Z. Lin, “Sodium β-aescin may be an effective therapeutic agent for Bell's palsy,” Medical Hypotheses, vol. 71, no. 5, pp. 762–764, 2008. View at Publisher · View at Google Scholar · View at Scopus
  104. C. Bougelet, I. H. Roland, N. Ninane, T. Arnould, J. Remacle, and C. Michiels, “Effect of aescine on hypoxia-induced neutrophil adherence to umbilical vein endothelium,” European Journal of Pharmacology, vol. 345, no. 1, pp. 89–95, 1998. View at Publisher · View at Google Scholar · View at Scopus
  105. X. Zhang, T. Zheng, L. Sang et al., “Otitis media induced by peptidoglycan-polysaccharide (PGPS) in TLR2-deficient (Tlr2-/-) mice for developing drug therapy,” Infection, Genetics and Evolution, vol. 35, pp. 194–203, 2015. View at Publisher · View at Google Scholar
  106. M. Rothkopf-Ischebeck, “Phenyl isothiocyanate pleurisy in rats-a model for the evaluation of anti-exudative substances,” Agents and Actions, vol. 8, no. 6, pp. 610–617, 1978. View at Publisher · View at Google Scholar · View at Scopus
  107. S.-J. Liu, S.-W. Zhou, and C.-S. Xue, “Effect of tetrandrine on neutrophilic recruitment response to brain ischemia/reperfusion,” Acta Pharmacologica Sinica, vol. 22, no. 11, pp. 971–975, 2001. View at Google Scholar · View at Scopus
  108. Y.-C. Shen, C.-F. Chen, and Y.-J. Sung, “Tetrandrine ameliorates ischaemia-reperfusion injury of rat myocardium through inhibition of neutrophil priming and activation,” British Journal of Pharmacology, vol. 128, no. 7, pp. 1593–1601, 1999. View at Publisher · View at Google Scholar · View at Scopus
  109. W. K. Seow, L. Si-Ying, and Y. H. Thong, “Inhibitory effects of tetrandrine on human neutrophil and monocyte adherence,” Immunology Letters, vol. 13, no. 1-2, pp. 83–88, 1986. View at Publisher · View at Google Scholar · View at Scopus
  110. Y.-C. Shen, C.-F. Chen, S.-Y. Wang, and Y.-J. Sung, “Impediment to calcium influx and reactive oxygen production accounts for the inhibition of neutrophil Mac-1 up-regulation and adhesion by tetrandrine,” Molecular Pharmacology, vol. 55, no. 1, pp. 186–193, 1999. View at Google Scholar · View at Scopus
  111. Y. Chen, Y.-H. Tsai, and S.-H. Tseng, “The potential of tetrandrine as a protective agent for ischemic stroke,” Molecules, vol. 16, no. 9, pp. 8020–8032, 2011. View at Publisher · View at Google Scholar · View at Scopus
  112. Y.-C. Shen, C.-J. Chou, W.-F. Chiou, and C.-F. Chen, “Anti-inflammatory effects of the partially purified extract of radix Stephaniae tetrandrae: comparative studies of its active principles tetrandrine and fangchinoline on human polymorphonuclear leukocyte functions,” Molecular Pharmacology, vol. 60, no. 5, pp. 1083–1090, 2001. View at Google Scholar · View at Scopus
  113. Z. Zhang, Z. Wu, X. Zhu, X. Hui, J. Pan, and Y. Xu, “Hydroxy-safflor yellow A inhibits neuroinflammation mediated by Aβ1–42 in BV-2 cells,” Neuroscience Letters, vol. 562, pp. 39–44, 2014. View at Publisher · View at Google Scholar · View at Scopus
  114. Y.-Q. Liu, H.-T. Zhou, and K.-S. Bi, “Study on distribution of safflor yellow A in tissues of mice,” Yao Xue Xue Bao, vol. 39, no. 3, pp. 217–219, 2004. View at Google Scholar · View at Scopus
  115. X. Wang, B. Zang, W. Wu, J. Tong, and M. Jin, “Protective effect of hydroxysafflor yellow A on endothelial cell injury induced by lipopolysaccharide,” Zhongguo Zhong Yao Za Zhi, vol. 36, no. 12, pp. 1650–1653, 2011. View at Publisher · View at Google Scholar · View at Scopus
  116. M. Jin, C.-Y. Sun, and B.-X. Zang, “Hydroxysafflor yellow A attenuate lipopolysaccharide-induced endothelium inflammatory injury,” Chinese Journal of Integrative Medicine, vol. 22, no. 1, pp. 36–41, 2016. View at Publisher · View at Google Scholar · View at Scopus
  117. L. Song, Y. Zhu, M. Jin, and B. Zang, “Hydroxysafflor yellow a inhibits lipopolysaccharide-induced inflammatory signal transduction in human alveolar epithelial A549 cells,” Fitoterapia, vol. 84, no. 1, pp. 107–114, 2013. View at Publisher · View at Google Scholar · View at Scopus
  118. X.-F. Wang, M. Jin, J. Tong, W. Wu, J.-R. Li, and B.-X. Zang, “Protective effect of hydroxysafflor yellow A against acute lung injury induced by oleic acid and lipopolysaccharide in rats,” Yao Xue Xue Bao, vol. 45, no. 7, pp. 940–944, 2010. View at Google Scholar · View at Scopus
  119. H. Wang, J. Liu, Y. Yang et al., “Hydroxy-safflower yellow a inhibits the TNFR1-mediated classical pathway by inducing shedding of TNFR1,” Phytotherapy Research, vol. 30, no. 5, pp. 790–796, 2016. View at Publisher · View at Google Scholar · View at Scopus
  120. S.-P. Lin, Y.-C. Hou, S.-Y. Tsai, M.-J. Wang, and P.-D. Lee Chao, “Tissue distribution of naringenin conjugated metabolites following repeated dosing of Naringin to rats,” BioMedicine, vol. 4, article 16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  121. S. F. Ahmad, S. M. Attia, S. A. Bakheet et al., “Naringin attenuates the development of carrageenan-induced acute lung inflammation through inhibition of NF-κb, STAT3 and pro-inflammatory mediators and enhancement of IκBα and anti-inflammatory cytokines,” Inflammation, vol. 38, no. 2, pp. 846–857, 2015. View at Publisher · View at Google Scholar · View at Scopus
  122. V. Gaur, A. Aggarwal, and A. Kumar, “Protective effect of naringin against ischemic reperfusion cerebral injury: possible neurobehavioral, biochemical and cellular alterations in rat brain,” European Journal of Pharmacology, vol. 616, no. 1–3, pp. 147–154, 2009. View at Publisher · View at Google Scholar · View at Scopus
  123. Y.-C. Nie, H. Wu, P.-B. Li et al., “Anti-inflammatory effects of naringin in chronic pulmonary neutrophilic inflammation in cigarette smoke-exposed rats,” Journal of Medicinal Food, vol. 15, no. 10, pp. 894–900, 2012. View at Publisher · View at Google Scholar · View at Scopus
  124. T. Hsueh, J. Sheen, J. Pang et al., “The anti-atherosclerotic effect of naringin is associated with reduced expressions of cell adhesion molecules and chemokines through NF-κB pathway,” Molecules, vol. 21, no. 2, article 195, 2016. View at Publisher · View at Google Scholar
  125. S.-C. Choe, H.-S. Kim, T.-S. Jeong, S.-H. Bok, and Y.-B. Park, “Naringin has an antiatherogenic effect with the inhibition of intercellular adhesion molecule-1 in hypercholesterolemic rabbits,” Journal of Cardiovascular Pharmacology, vol. 38, no. 6, pp. 947–955, 2001. View at Publisher · View at Google Scholar · View at Scopus
  126. S.-W. Kim, C. E. Kim, and M. H. Kim, “Flavonoids inhibit high glucose-induced up-regulation of ICAM-1 via the p38 MAPK pathway in human vein endothelial cells,” Biochemical and Biophysical Research Communications, vol. 415, no. 4, pp. 602–607, 2011. View at Publisher · View at Google Scholar · View at Scopus
  127. A. Chanet, D. Milenkovic, C. Deval et al., “Naringin, the major grapefruit flavonoid, specifically affects atherosclerosis development in diet-induced hypercholesterolemia in mice,” Journal of Nutritional Biochemistry, vol. 23, no. 5, pp. 469–477, 2012. View at Publisher · View at Google Scholar · View at Scopus
  128. W. Wang, J. Xu, L. Li et al., “Neuroprotective effect of morroniside on focal cerebral ischemia in rats,” Brain Research Bulletin, vol. 83, no. 5, pp. 196–201, 2010. View at Publisher · View at Google Scholar · View at Scopus
  129. X. Li, Q. Wang, X. Zhang et al., “HPLC study of pharmacokinetics and tissue distribution of morroniside in rats,” Journal of Pharmaceutical and Biomedical Analysis, vol. 45, no. 2, pp. 349–355, 2007. View at Publisher · View at Google Scholar · View at Scopus
  130. F.-L. Sun, W. Wang, H. Cheng et al., “Morroniside improves microvascular functional integrity of the neurovascular unit after cerebral ischemia,” PLoS ONE, vol. 9, no. 6, Article ID e101194, 2014. View at Publisher · View at Google Scholar · View at Scopus
  131. B. Lapergue, A. Mohammad, and A. Shuaib, “Endothelial progenitor cells and cerebrovascular diseases,” Progress in Neurobiology, vol. 83, no. 6, pp. 349–362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  132. M. Digicaylioglu, “Erythropoietin in stroke: quo vadis,” Expert Opinion on Biological Therapy, vol. 10, no. 6, pp. 937–949, 2010. View at Publisher · View at Google Scholar · View at Scopus
  133. I. Torres-Aleman, “Toward a comprehensive neurobiology of IGF-I,” Developmental Neurobiology, vol. 70, no. 5, pp. 384–396, 2010. View at Publisher · View at Google Scholar · View at Scopus
  134. J. Kim, T.-J. Song, J. H. Park et al., “Different prognostic value of white blood cell subtypes in patients with acute cerebral infarction,” Atherosclerosis, vol. 222, no. 2, pp. 464–467, 2012. View at Publisher · View at Google Scholar · View at Scopus